Transdermal buprenorphine dosage regimen for analgesia

Details Transdermal buprenorphine dosage regimen for analgesia Transdermal buprenorphine dosage regimen for analgesia

2007-09-18

2007-09-18

Kennedy, Sharon E. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

Reexamination Certificate

active

10736043

ABSTRACT:
Dosage regimens of buprenorphine achieving rapid pain relief without increasing nausea, vomiting, or other adverse effects, are described. Also described are buprenorphine dosage regimens for treating chronic pain comprising administering to the patient (1) a first buprenorphine-containing transdermal dosage form for a first dosing period that is no more than about 5 days; (2) a second buprenorphine-containing transdermal dosage form for a second dosing period that is no more than 5 days, the second dosage form comprising the same dosage of buprenorphine as, or a greater dosage of buprenorphine than, the first dosage form; and (3) a third buprenorphine-containing transdermal dosage form for a third dosing period, the third dosage form comprising a greater dosage of buprenorphine than the second dosage form.

REFERENCES:
patent: 4806341 (1989-02-01), Chien et al.
patent: 5026556 (1991-06-01), Drust et al.
patent: 5069909 (1991-12-01), Sharma et al.
patent: 5149538 (1992-09-01), Granger et al.
patent: 5225199 (1993-07-01), Hidaka et al.
patent: 5240711 (1993-08-01), Hille et al.
patent: 5613958 (1997-03-01), Kochinke et al.
patent: 5968547 (1999-10-01), Reder et al.
patent: 2001/0002259 (2001-05-01), Reder et al.
patent: WO-03/079945 (2003-10-01), None
patent: WO-2004/103317 (2004-12-01), None
patent: WO-2005/011579 (2005-02-01), None
Adrianensen et al., Acta Anaesthesiol Belg 1985;36:33-40.
Brema et al., Int J Clin Pharmacol Res 1996;16:109-116.
Capogna et al., Anaesthesia 1988, 43:128-130.
Goodman & Gilman's The Pharmacological Basis of Therapeutics, J.G. Hardman (Ed.), McGraw-Hill Professional Publishing 2001, pp. 530-532.
Hale et al., Abstract, 08 GSA 2001.
Hale et al., Abstract, Nat'l Clin. Symposium of the American College of Nurse Practitioners; Oct. 2001.
Hale et al., J. Clin. Pharmacol. 2001; 41(9):1027, Abstract 58.
Heel et al., Drugs 1979;17:81-110.
Inagaki et al., Anesth Analg 1996;83:530-536.
Nasar et al., Curr Med Res Opin 1986;10:251-255.
Oda et al., Br. J. Anaesthesia 1999;82(6):900-903.
Reidenberg et al., J. Clin. Pharmacol. 2001;41(9):1027, Abstract 57.
Spyker et al., J. Amer. Geriatrics Soc. 2002;50(4):S66, Abstract P162.
Spyker et al., J. Pain 2002;3(2, Suppl. 1):12, Abstract 645.
Spyker et al., J. Pain 2002;3(2,Suppl 1):14, Abstract 653.
Spyker et al., Clin. Pharmacol. Ther. 2000;67(2):145, Abstract PIII-12.
Spyker et al., Clin. Pharmacol. Ther. 2001;69(2):P33, Abstract PII-3.
Spyker et al., Conference Abstract presented on Oct. 15, 2001.
Tauzin-Fin et al., Eur J Anaesthesiol 1998;15:147-152.
Ahmedzai, Eur. J. Cancer 1997;33:58-514.
Bentley et al., Anesth Anal 1982;61:968-971.
Cathelin et al., Anesth Anal (Paris). 1980;37(5-6):283-93.
Dayer et al., Drugs 1997;53:18-24.
Holdsworth et al., Gerontology 1994;40:32-37.
Jeal and Benfield, Drugs 1997;53:109-138.
Melon et al., Anesth Anal Rean 1980;37:121-125.
Mercandente, Cancer 1999;86:1856-66.
Mercadente and Fulfaro, Oncology 1999;13:215-220, 225.
Thompson et al., Br J Anaesth 1998;81:152-154.
Reidenberg et al., “Physiologic Effects of Buprenorphine Transdermal System (BTDS) Dose Escalation in the Young, Healthy Elderly and elderly Hypertensive Subjects,” BIOSIS, Mar. 7, 2001; XP002389136; Meeting Abstract.

Affiliated with

Also associated with

Rating

Transdermal buprenorphine dosage regimen for analgesia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal buprenorphine dosage regimen for analgesia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal buprenorphine dosage regimen for analgesia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3748315